儿童肝炎相关无形性贫血的临床特征
Lingling Fu1, Jialu Zhang1, Ruixin Wang1
1Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Children, Ministry of Education, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.
在儿童中,肝炎相关的无形性贫血 (HAAA) 经常显示细胞毒性T淋巴细胞的增加. 免疫抑制疗法 (IST) 在大多数儿科HAAA病例中是有效的,但同时感染可能会延迟治疗反应.
科学领域:
- 儿科血液学 儿科血液学
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 肝炎相关的无形性贫血 (HAAA) 是儿童罕见但严重的疾病.
- 了解HAAA的特征和预后对于有效管理至关重要.
研究的目的:
- 分析儿科HAAA的临床特征和预后.
- 在HAAA患者中评估免疫抑制疗法 (IST) 的疗效.
- 在HAAA中确定影响治疗结果的因素.
主要方法:
- 81名儿科HAAA患者的回顾性分析 (2017年2月 - 2022年5月).
- 评估疾病严重程度 (SAA,VSAA,NSAA) 和免疫细胞概况 (CTL,CD4/CD8比率).
- 对IST疗效的评估和对影响因素的多变量分析.
主要成果:
- 发病年龄的中位数为5.9岁; 28.5%患有严重的无形成性贫血 (SAA).
- 观察到细胞毒性T淋巴细胞 (CTL) 水平升高和CD4/CD8比率低.
- IST显示总体响应率为73.5%,同时感染是延迟响应的危险因素.
结论:
- 儿科HAAA的特点是免疫失调,包括增加的CTLs.
- IST对于儿科HAAA是一种可行的治疗选择,实现了高响应率.
- 同时感染是影响IST疗效和治疗持续时间的重要因素.
更多相关视频
09:44Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
相关概念视频
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Regulation of Hematopoietic Stem Cells
